ImmuPharma PLC (LON:IMM) said recruitment for the phase III clinical trial of its drug Lupuzor for the autoimmune disease Lupus remains on track with 11 sites in the US now up and running.
A further five centres - Czech Republic, France, Germany, Hungary and Poland – are currently recruiting patients, while studies in the UK and Italy will begin in the “next few weeks”.
In other news, shares in Premier African Minerals Ltd (LON:PREM) rocketed as it revealed serial small cap firm promoter and lithium expert David Lenigas has got aboard its Zimbabwe Zulu project.
The entrepreneur has been hired to carry out an independent review of the project, where drilling has now started - looking at potential strategic investors or joint ventures as well as financing.
Over at Cello Group plc (LON:CLL), the firm raised its interim dividend by 19% as it drew a line under its dispute with the UK tax office.
Mark Scott, chief executive, said the group was back on a growth path following the VAT issue.
Elsewhere, Ariana Resources plc (LON:AAU) may increase the size of one of the pits at its new mine at Kiziltepe in Turkey after drilling confirmed gold signs outside the original area.
Drilling to the north west of the boundary of the proposed Arzu South pit confirmed a parallel vein system.
Over at Falcon Oil & Gas Ltd (LON:FOG), the company has confirmed significant indications of gas in both the Middle Velkerri and Lower Kyalla formations at W-1 well it the Beetaloo Basin in Australia.
“Excellent gas shows” were discovered at two prospective shale sweet spots at the top and base of the Middle Velkerri formation, which Falcon said was comparable to those encountered during last year’s drilling programme.
Next, Digital Barriers PLC (LON:DGB) has bagged a US$2.2mln contract with a US Federal law enforcement agency, which wants to use the group's EdgeVis Live advanced wireless surveillance technology.
The company said the revenue associated with this contract should be fully recognised in this financial year and lead to further material awards, both this year and in subsequent years.
Meanwhile, shares in Stratmin Global Resources PLC (LON:STGR) gained almost 30% after the AIM-listed firm announced it had completed the divestment of Graphmada Mauritius.
Stratmin said it had executed a final settlement deed and should receive the final A$600,000 of the A$1.5mln tranche one cash payment from Bass Metals Ltd within the next 24 hours.
Telit Communications Plc (LON:TCM) told investors last month that it would pay an interim of 2.5c per share, which it has now calculated to be 1.85p per share in sterling.
Elsehwere, Galasys PLC’s (LON:GLS) boardroom dispute rumbles on as the trial due to be held on 20 September has now been adjourned until 26 September.
Sierra Rutile Ltd (LON:SRX) says it is still in discussion with Iluka Investments about a potential merger as it waits to hear back from the German takeover authority.
The German antitrust authority recently initiated Phase II proceedings which means it could be three months until a final decision is made.
And finally, gaming and slot machine software group Quixant plc (LON:QXT) came up trumps with its half-year results.
The shares were up 9.1% at 240p in late morning trade as the core gaming division saw strong growth in the top line and profits while the recently acquired Densitron division, which specialises in electronic screens, made a healthy contribution.